Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
Many Black people in the U.S. are born into a life of trauma, and this trauma is born from a history of repression, violence, injustice, and inhumanity. This trauma is not something any of us who have not been Black in America can ever fully understand; it is a very personal, lived experience. The goal […]
Many Black people in the U.S. are born into a life of trauma, and this trauma is born from a history of repression, violence, injustice, and inhumanity. This trauma is not something any of us who have not been Black in America can ever fully understand; it is a very personal, lived experience. The goal […]
Leaders in nephrology will discuss healthcare challenges amidst COVID-19, telemedicine, and the future of nephrology.
Leaders in nephrology will discuss healthcare challenges amidst COVID-19, telemedicine, and the future of nephrology. *Speakers are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc (OPDC). Tazin Aijaz, PharmD, BCPS is an employee of OPDC. Featured Speakers Location Online via NephU.org
This presentation on Dietary Factors & Polycystic Kidney Disease (PKD): Dietary Interventions, reviews human composite dietary intervention trials conducted in patients with autosomal dominant polycystic kidney disease (ADPKD). These dietary interventions include reductions in dietary sodium and protein to reduce solute load, increasing fluid intake to control vasopressin, and increasing fruit and vegetable intake to […]
This presentation on Dietary Factors & Polycystic Kidney Disease (PKD): Dietary Interventions, reviews human composite dietary intervention trials conducted in patients with autosomal dominant polycystic kidney disease (ADPKD). These dietary interventions include reductions in dietary sodium and protein to reduce solute load, increasing fluid intake to control vasopressin, and increasing fruit and vegetable intake to […]
Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology. This is a Regional Virtual Live Event for the Garden State Chapter of […]
Join us as we discuss the challenges patients with end-stage kidney disease face and explore the barriers and benefits of living kidney donation. Our speaker, Glenna Frey, APRN-CNS, is an advanced practice provider with over 35 years of nephrology nursing and oncology experience. Apart from being a healthcare provider, Glenna Frey is the co-founder and […]
Join us as we discuss the challenges patients with end-stage kidney disease face and explore the barriers and benefits of living kidney donation. Our speaker, Glenna Frey, APRN-CNS, is an advanced practice provider with over 35 years of nephrology nursing and oncology experience. Apart from being a healthcare provider, Glenna Frey is the co-founder and […]
Did you know that Black patients with autosomal dominant polycystic kidney disease (ADPKD) progress to end-stage kidney disease (ESKD) earlier than White patients?1,2 Please join us for a virtual panel discussion, led by nephrology experts, where you can hear about the racial disparities that exist in autosomal dominant polycystic kidney disease (ADPKD), underrepresentation of Black […]
Did you know that Black patients with autosomal dominant polycystic kidney disease (ADPKD) progress to end-stage kidney disease (ESKD) earlier than White patients?1,2 Please join us for a virtual panel discussion, led by nephrology experts, where you can hear about the racial disparities that exist in autosomal dominant polycystic kidney disease (ADPKD), underrepresentation of Black […]
Clinical pharmacy services have the potential to contribute significantly to the multidisciplinary team by providing safe, effective, and economic care for patients. Given recent practice developments (e.g. polypharmacy reviews and pharmacist prescribing), there is a need to provide a current synthesis of evidence-based characteristics and outcomes of clinical pharmacy practice in treating patients with chronic […]
